Kinfo
Cumberland Pharmaceuticals Inc. logo

Cumberland Pharmaceuticals Inc.

CPIXNASDAQHealthcare·US · USD
$7.17
+0.17 (+2.43%)
Prices as of October 13, 2026 · market closed

Price

Key statistics

Valuation
Market cap104.88M USD
Enterprise value105.40M USD
Trailing P/E-37.84
Forward P/E50.00
PEG ratio-0.09
Price / sales2.37
Price / book6.01
Profitability
Gross margin0.00%
Operating margin-1898.65%
Profit margin-24.64%
Return on assets-2.91%
Return on equity-14.39%
Income (TTM)
Revenue44.30M USD
Gross profit37.64M USD
EBITDA2.97M USD
Net income-3.20M USD
Diluted EPS-$0.62
Rev. growth (YoY)-56.30%
Balance sheet
Total cash3.86M USD
Total debt4.71M USD
Debt / equity27.56
Current ratio0.96
Book value / share$1.16
Cash flow (TTM)
Operating cash flow745.97K USD
Levered free cash flow-191.17K USD
Shares & price
Shares outstanding14.98M
Float8.70M
Held by institutions16.56%
Beta0.04
50-day MA$7.43
200-day MA$5.37
52-week high$9.28
52-week low$1.85
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Recent payments
  • 2026-08-03$1.50
Earnings (EPS)
DateEst.ActualSurprise2026-04-293.694.10+11.11%2025-09-301.881.88+0.00%2023-03-06—-0.05—2022-11-07—0.10—2022-08-08-0.07-0.01+85.71%
About Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing, acquiring, and commercializing branded prescription medicines for hospital acute care and other specialized treatment settings. Cumberland Pharmaceuticals markets a portfolio of approved products used in areas such as pain and fever management, nausea and vomiting prevention, constipation, hyponatremia, and certain bacterial infections. Its business centers on delivering therapies for physicians, hospitals, and patients who need targeted prescription treatments in areas where standard options may be limited or highly specialized. The company also operates in therapeutic markets including gastroenterology, oncology support, and critical care, reflecting its emphasis on products used in acute and hospital-based care. Cumberland Pharmaceuticals plays a niche role in the healthcare market by focusing on prescription medicines designed for specific clinical needs rather than broad consumer health products.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. A. J. Kazimi MBA
Employees
88
Headquarters
Nashville, TN, United States

Frequently asked questions about Cumberland Pharmaceuticals Inc.